{"transactions":[{"id":734224,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-18T00:30:45.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":73434,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units vest in full on the earlier of (i) the one-year anniversary of June 16, 2026 and (ii) the date of the 2027 Annual Meeting of Stockholders, subject to Reporting Person's continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2031; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors)."}],"balance_after":207352,"source":{"system":"sec-edgar","filing":"0001809519-26-000125","document":"wk-form4_1781742642.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809519/000180951926000125/wk-form4_1781742642.xml","form_type":"4"}},{"id":758811,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-29T21:58:05.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":4642,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units will vest as to 2% of the underlying shares on May 31, 2026, and the remining 98% will vest in substantially equal monthly installments on last day of each month over the following 7 months, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2031; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors)."}],"balance_after":133918,"source":{"system":"sec-edgar","filing":"0001809519-26-000117","document":"wk-form4_1780091882.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809519/000180951926000117/wk-form4_1780091882.xml","form_type":"4"}},{"id":911787,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-10T22:45:23.000Z","date":"2026-02-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":6801,"price":187.49,"value":1275119.49,"ownership":{"direct":true},"balance_after":44103,"source":{"system":"sec-edgar","filing":"0001628280-26-006952","document":"wk-form4_1770763520.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478242/000162828026006952/wk-form4_1770763520.xml","form_type":"4"}},{"id":911786,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-10T22:45:23.000Z","date":"2026-02-08","kind":"grant","planned":false,"acquired":true,"shares":16335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 13, 2023. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 8, 2026."}],"balance_after":50904,"source":{"system":"sec-edgar","filing":"0001628280-26-006952","document":"wk-form4_1770763520.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478242/000162828026006952/wk-form4_1770763520.xml","form_type":"4"}},{"id":951770,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-05T22:18:49.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":18251,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units will vest in substantially equal monthly installments beginning on January 31, 2026 and ending on December 31, 2026, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2031; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors)."}],"balance_after":129276,"source":{"system":"sec-edgar","filing":"0001809519-26-000003","document":"wk-form4_1767651526.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809519/000180951926000003/wk-form4_1767651526.xml","form_type":"4"}},{"id":1003798,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Unit","published_at":"2025-11-10T22:13:45.000Z","date":"2025-11-08","kind":"exercise","planned":false,"acquired":false,"shares":21691,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The deferred stock unit award vested as to one-third of the shares underlying the award on November 8, 2025. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The deferred stock unit award vested as to one-third of the shares underlying the award on November 8, 2025. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors)."}],"balance_after":43384,"derivative":{"underlying":"Class A Common Stock","underlying_shares":21691},"source":{"system":"sec-edgar","filing":"0001809519-25-000145","document":"wk-form4_1762812823.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1809519/000180951925000145/wk-form4_1762812823.xml","form_type":"4"}},{"id":1003797,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-10T22:13:45.000Z","date":"2025-11-08","kind":"exercise","planned":false,"acquired":true,"shares":21691,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The deferred stock unit award vested as to one-third of the shares underlying the award on November 8, 2025. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."}],"balance_after":111025,"source":{"system":"sec-edgar","filing":"0001809519-25-000145","document":"wk-form4_1762812823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809519/000180951925000145/wk-form4_1762812823.xml","form_type":"4"}},{"id":1123052,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-04T22:49:15.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":57050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units vest in full on the earlier of (i) the one-year anniversary of June 3, 2025 and (ii) the date of the 2026 Annual Meeting of Stockholders, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors)."}],"balance_after":89334,"source":{"system":"sec-edgar","filing":"0001809519-25-000090","document":"wk-form4_1749077349.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809519/000180951925000090/wk-form4_1749077349.xml","form_type":"4"}},{"id":1271590,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-12T22:12:28.000Z","date":"2025-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":907,"price":206.97,"value":187721.79,"ownership":{"direct":true},"balance_after":34569,"source":{"system":"sec-edgar","filing":"0001478242-25-000037","document":"wk-form4_1739398341.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478242/000147824225000037/wk-form4_1739398341.xml","form_type":"4"}},{"id":1290741,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Appreciation Right","published_at":"2025-01-30T22:55:21.000Z","date":"2025-01-28","kind":"grant","planned":false,"acquired":true,"shares":31603,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This stock appreciation right vests in three annual installments beginning on January 28, 2026."}],"balance_after":31603,"derivative":{"exercise_price":203.43,"expiration_date":"2035-01-28","underlying":"Common Stock","underlying_shares":31603},"source":{"system":"sec-edgar","filing":"0001478242-25-000008","document":"wk-form4_1738277713.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478242/000147824225000008/wk-form4_1738277713.xml","form_type":"4"}},{"id":1290740,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-01-30T22:55:21.000Z","date":"2025-01-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":2201,"price":203.43,"value":447749.43,"ownership":{"direct":true},"balance_after":35476,"source":{"system":"sec-edgar","filing":"0001478242-25-000008","document":"wk-form4_1738277713.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478242/000147824225000008/wk-form4_1738277713.xml","form_type":"4"}},{"id":1290739,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-01-30T22:55:21.000Z","date":"2025-01-28","kind":"grant","planned":false,"acquired":true,"shares":6286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 10, 2022. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on  January 28, 2025."}],"balance_after":37677,"source":{"system":"sec-edgar","filing":"0001478242-25-000008","document":"wk-form4_1738277713.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478242/000147824225000008/wk-form4_1738277713.xml","form_type":"4"}},{"id":1315061,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-01-04T00:07:48.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":10653,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units will vest in substantially equal monthly installments beginning on January 31, 2025 and ending on December 31, 2025, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors)."}],"balance_after":32284,"source":{"system":"sec-edgar","filing":"0001809519-25-000002","document":"wk-form4_1735949262.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809519/000180951925000002/wk-form4_1735949262.xml","form_type":"4"}},{"id":1369127,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Unit","published_at":"2024-11-12T22:39:25.000Z","date":"2024-11-08","kind":"grant","planned":false,"acquired":true,"shares":65075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each deferred stock unit represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The deferred stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on November 8, 2025, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The deferred stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on November 8, 2025, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors)."}],"balance_after":65075,"derivative":{"underlying":"Class A Common Stock","underlying_shares":65075},"source":{"system":"sec-edgar","filing":"0001809519-24-000202","document":"wk-form4_1731451158.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1809519/000180951924000202/wk-form4_1731451158.xml","form_type":"4"}},{"id":1369126,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-11-12T22:39:25.000Z","date":"2024-11-08","kind":"grant","planned":false,"acquired":true,"shares":20503,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects deferred stock units. Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units vest in full on the earlier of (i) June 6, 2025 and (ii) the date of the 2025 Annual Meeting of Stockholders, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors)."}],"balance_after":21631,"source":{"system":"sec-edgar","filing":"0001809519-24-000202","document":"wk-form4_1731451158.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1809519/000180951924000202/wk-form4_1731451158.xml","form_type":"4"}},{"id":1369125,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-11-12T22:39:25.000Z","date":"2024-11-08","kind":"grant","planned":false,"acquired":true,"shares":1128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units will vest in substantially equal monthly installments on the last calendar day for each remaining month of the 2024 calendar year, beginning on November 30, 2024, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors)."}],"balance_after":1128,"source":{"system":"sec-edgar","filing":"0001809519-24-000202","document":"wk-form4_1731451158.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809519/000180951924000202/wk-form4_1731451158.xml","form_type":"4"}},{"id":1646027,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-02-13T22:08:27.000Z","date":"2024-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":907,"price":218.2,"value":197907.4,"ownership":{"direct":true},"balance_after":31391,"source":{"system":"sec-edgar","filing":"0001478242-24-000027","document":"wk-form4_1707862086.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478242/000147824224000027/wk-form4_1707862086.xml","form_type":"4"}},{"id":1646026,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-02-13T22:08:27.000Z","date":"2024-02-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":1033,"price":218.2,"value":225400.6,"ownership":{"direct":true},"balance_after":32298,"source":{"system":"sec-edgar","filing":"0001478242-24-000027","document":"wk-form4_1707862086.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478242/000147824224000027/wk-form4_1707862086.xml","form_type":"4"}},{"id":1653374,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Appreciation Right","published_at":"2024-02-08T22:18:56.000Z","date":"2024-02-07","kind":"grant","planned":false,"acquired":true,"shares":20719,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock appreciation right vests in three annual installments beginning on February  7, 2025."}],"balance_after":20719,"derivative":{"exercise_price":214.34,"expiration_date":"2034-02-07","underlying":"Common Stock","underlying_shares":20719},"source":{"system":"sec-edgar","filing":"0001478242-24-000016","document":"wk-form4_1707430726.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478242/000147824224000016/wk-form4_1707430726.xml","form_type":"4"}},{"id":1653373,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-02-08T22:18:56.000Z","date":"2024-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":10514,"price":215.41,"value":2264820.74,"ownership":{"direct":true},"balance_after":33331,"source":{"system":"sec-edgar","filing":"0001478242-24-000016","document":"wk-form4_1707430726.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478242/000147824224000016/wk-form4_1707430726.xml","form_type":"4"}},{"id":1653372,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-02-08T22:18:56.000Z","date":"2024-02-06","kind":"grant","planned":false,"acquired":true,"shares":24141,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February  9, 2021. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 6, 2024."}],"balance_after":43845,"source":{"system":"sec-edgar","filing":"0001478242-24-000016","document":"wk-form4_1707430726.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478242/000147824224000016/wk-form4_1707430726.xml","form_type":"4"}},{"id":1813799,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-08-07T21:09:30.000Z","date":"2023-08-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":2588,"price":216.29,"value":559758.52,"ownership":{"direct":true},"balance_after":19704,"source":{"system":"sec-edgar","filing":"0001478242-23-000089","document":"wk-form4_1691442559.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478242/000147824223000089/wk-form4_1691442559.xml","form_type":"4"}},{"id":2013527,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Appreciation Right","published_at":"2023-02-15T23:01:26.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":20600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock appreciation right vests in three annual installments beginning on February 13, 2024."}],"balance_after":20600,"derivative":{"exercise_price":232.11,"expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":20600},"source":{"system":"sec-edgar","filing":"0001478242-23-000048","document":"wf-form4_167650206856410.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478242/000147824223000048/wf-form4_167650206856410.xml","form_type":"4"}},{"id":2019893,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-02-13T22:04:47.000Z","date":"2023-02-10","kind":"tax_withholding","acquired":false,"shares":614,"price":222.84,"value":136823.76,"ownership":{"direct":true},"balance_after":22292,"source":{"system":"sec-edgar","filing":"0001478242-23-000028","document":"wf-form4_167632584887189.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478242/000147824223000028/wf-form4_167632584887189.xml","form_type":"4"}},{"id":2019892,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-02-13T22:04:47.000Z","date":"2023-02-09","kind":"tax_withholding","acquired":false,"shares":717,"price":230.31,"value":165132.27,"ownership":{"direct":true},"balance_after":22906,"source":{"system":"sec-edgar","filing":"0001478242-23-000028","document":"wf-form4_167632584887189.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478242/000147824223000028/wf-form4_167632584887189.xml","form_type":"4"}},{"id":2193205,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-08-05T21:16:12.000Z","date":"2022-08-03","kind":"tax_withholding","acquired":false,"shares":2588,"price":233.21,"value":603547.48,"ownership":{"direct":true},"balance_after":23623,"source":{"system":"sec-edgar","filing":"0001478242-22-000090","document":"wf-form4_165973415234229.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478242/000147824222000090/wf-form4_165973415234229.xml","form_type":"4"}},{"id":2388371,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-02-17T22:03:03.000Z","date":"2021-10-25","kind":"sale","acquired":false,"shares":4,"price":256.93,"value":1027.72,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The purchase and sale transactions were made without Mr. Bruehlman's knowledge by an independent financial broker/advisor who manages an investment account on Mr. Bruehlman's behalf."}],"balance_after":26224,"source":{"system":"sec-edgar","filing":"0001478242-22-000043","document":"wf-form4_164513535199187.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478242/000147824222000043/wf-form4_164513535199187.xml","form_type":"4"}},{"id":2388370,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-02-17T22:03:03.000Z","date":"2021-09-23","kind":"purchase","acquired":true,"shares":4,"price":262.82,"value":1051.28,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The purchase and sale transactions were made without Mr. Bruehlman's knowledge by an independent financial broker/advisor who manages an investment account on Mr. Bruehlman's behalf."}],"balance_after":26228,"source":{"system":"sec-edgar","filing":"0001478242-22-000043","document":"wf-form4_164513535199187.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478242/000147824222000043/wf-form4_164513535199187.xml","form_type":"4"}},{"id":2397852,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Appreciation Right","published_at":"2022-02-14T22:06:43.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":21849,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock appreciation right vests in three annual installments beginning on February 10, 2023."}],"balance_after":21849,"derivative":{"exercise_price":250.43,"expiration_date":"2032-02-10","underlying":"Common Stock","underlying_shares":21849},"source":{"system":"sec-edgar","filing":"0001478242-22-000022","document":"wf-form4_164487637172562.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478242/000147824222000022/wf-form4_164487637172562.xml","form_type":"4"}},{"id":2397851,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-02-14T22:06:43.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":5869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units that will vest in three annual installments beginning on February 10, 2023."}],"balance_after":26224,"source":{"system":"sec-edgar","filing":"0001478242-22-000022","document":"wf-form4_164487637172562.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478242/000147824222000022/wf-form4_164487637172562.xml","form_type":"4"}},{"id":2397850,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-02-14T22:06:43.000Z","date":"2021-07-20","kind":"purchase","acquired":true,"shares":13,"price":245.32,"value":3189.16,"ownership":{"direct":true},"balance_after":20355,"source":{"system":"sec-edgar","filing":"0001478242-22-000022","document":"wf-form4_164487637172562.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478242/000147824222000022/wf-form4_164487637172562.xml","form_type":"4"}},{"id":2401557,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-02-11T22:08:35.000Z","date":"2022-02-09","kind":"tax_withholding","acquired":false,"shares":705,"price":255.57,"value":180176.85,"ownership":{"direct":true},"balance_after":20342,"source":{"system":"sec-edgar","filing":"0001478242-22-000020","document":"wf-form4_164461729807520.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478242/000147824222000020/wf-form4_164461729807520.xml","form_type":"4"}},{"id":2612949,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-08-05T21:03:53.000Z","date":"2021-08-03","kind":"tax_withholding","acquired":false,"shares":2391,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":21047,"source":{"system":"sec-edgar","filing":"0001478242-21-000052","document":"wf-form4_162819736861943.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478242/000147824221000052/wf-form4_162819736861943.xml","form_type":"4"}},{"id":2866560,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Appreciation Right","published_at":"2021-02-11T22:17:18.000Z","date":"2021-02-09","kind":"grant","acquired":true,"shares":26701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock appreciation right vests in three annual installments beginning on February 9, 2022."}],"balance_after":26701,"derivative":{"exercise_price":183.82,"expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":26701},"source":{"system":"sec-edgar","filing":"0001478242-21-000007","document":"wf-form4_161308182421437.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478242/000147824221000007/wf-form4_161308182421437.xml","form_type":"4"}},{"id":2866559,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-02-11T22:17:18.000Z","date":"2021-02-09","kind":"grant","acquired":true,"shares":6687,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":23438,"source":{"system":"sec-edgar","filing":"0001478242-21-000007","document":"wf-form4_161308182421437.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478242/000147824221000007/wf-form4_161308182421437.xml","form_type":"4"}},{"id":2879138,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-02-04T22:18:23.000Z","date":"2020-12-10","kind":"gift","acquired":false,"shares":60,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":28631,"source":{"system":"sec-edgar","filing":"0001478242-21-000004","document":"wf-form5_161247709071920.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478242/000147824221000004/wf-form5_161247709071920.xml","form_type":"5"}},{"id":2879137,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-02-04T22:18:23.000Z","date":"2020-12-09","kind":"gift","acquired":false,"shares":60,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":28691,"source":{"system":"sec-edgar","filing":"0001478242-21-000004","document":"wf-form5_161247709071920.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478242/000147824221000004/wf-form5_161247709071920.xml","form_type":"5"}},{"id":3067390,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-08-05T21:02:52.000Z","date":"2020-08-04","kind":"purchase","acquired":true,"shares":10000,"price":159.94,"value":1599400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price for shares purchased in multiple transactions. The purchase prices range from $159.75 to $160.04 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":26751,"source":{"system":"sec-edgar","filing":"0001478242-20-000058","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478242/000147824220000058/edgar.xml","form_type":"4"}},{"id":3067389,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-08-05T21:02:52.000Z","date":"2020-08-03","kind":"grant","acquired":true,"shares":16751,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units that will vest in three annual installments beginning on August 3, 2021."}],"balance_after":16751,"source":{"system":"sec-edgar","filing":"0001478242-20-000058","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478242/000147824220000058/edgar.xml","form_type":"4"}},{"id":4589816,"issuer":{"id":174539,"kind":"organization","name":"IMS Health Holdings, Inc.","symbol":"Q"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Appreciation Right","published_at":"2016-10-03T18:54:18.000Z","date":"2016-10-03","kind":"disposition_to_issuer","acquired":false,"shares":79745,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 30,622 shares of Quintiles IMS Holdings, Inc. common stock at a price of  $59.90 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"This stock appreciation right vests in four annual installments beginning on February 2, 2017."}],"balance_after":0,"derivative":{"exercise_price":23,"expiration_date":"2026-02-02","underlying":"Common Stock","underlying_shares":79745},"source":{"system":"sec-edgar","filing":"0001595262-16-000063","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1595262/000159526216000063/edgar.xml","form_type":"4"}},{"id":4589815,"issuer":{"id":174539,"kind":"organization","name":"IMS Health Holdings, Inc.","symbol":"Q"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Appreciation Right","published_at":"2016-10-03T18:54:18.000Z","date":"2016-10-03","kind":"disposition_to_issuer","acquired":false,"shares":35397,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 13,592 shares of Quintiles IMS Holdings, Inc. common stock at a price of  $65.16 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"This stock appreciation right vests in three annual installments beginning on February 10, 2017."}],"balance_after":0,"derivative":{"exercise_price":25.02,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":35397},"source":{"system":"sec-edgar","filing":"0001595262-16-000063","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1595262/000159526216000063/edgar.xml","form_type":"4"}},{"id":4589814,"issuer":{"id":174539,"kind":"organization","name":"IMS Health Holdings, Inc.","symbol":"Q"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Appreciation Right","published_at":"2016-10-03T18:54:18.000Z","date":"2016-10-03","kind":"disposition_to_issuer","acquired":false,"shares":11798,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 4,530 shares of Quintiles IMS Holdings, Inc. common stock at a price of  $65.16 per share."}],"balance_after":0,"derivative":{"exercise_price":25.02,"exercise_date":"2016-02-10","expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":11798},"source":{"system":"sec-edgar","filing":"0001595262-16-000063","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1595262/000159526216000063/edgar.xml","form_type":"4"}},{"id":4589813,"issuer":{"id":174539,"kind":"organization","name":"IMS Health Holdings, Inc.","symbol":"Q"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employees Stock Option (right to buy)","published_at":"2016-10-03T18:54:18.000Z","date":"2016-10-03","kind":"disposition_to_issuer","acquired":false,"shares":230000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This option was assumed by Quintiles in the merger and replaced with an option to purchase 88,320 shares of Quintiles IMS Holdings, Inc. common stock at a price of $11.46 per share."}],"balance_after":0,"derivative":{"exercise_price":4.4,"exercise_date":"2016-07-16","expiration_date":"2021-07-16","underlying":"Common Stock","underlying_shares":230000},"source":{"system":"sec-edgar","filing":"0001595262-16-000063","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1595262/000159526216000063/edgar.xml","form_type":"4"}},{"id":4589812,"issuer":{"id":174539,"kind":"organization","name":"IMS Health Holdings, Inc.","symbol":"Q"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employees Stock Option (right to buy)","published_at":"2016-10-03T18:54:18.000Z","date":"2016-10-03","kind":"disposition_to_issuer","acquired":false,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This option was assumed by Quintiles in the merger and replaced with an option to purchase 23,040 shares of Quintiles IMS Holdings, Inc. common stock at a price of $18.23 per share."}],"balance_after":0,"derivative":{"exercise_price":7,"exercise_date":"2013-07-16","expiration_date":"2021-07-16","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001595262-16-000063","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1595262/000159526216000063/edgar.xml","form_type":"4"}},{"id":4589811,"issuer":{"id":174539,"kind":"organization","name":"IMS Health Holdings, Inc.","symbol":"Q"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employees Stock Option (right to buy)","published_at":"2016-10-03T18:54:18.000Z","date":"2016-10-03","kind":"disposition_to_issuer","acquired":false,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This option was assumed by Quintiles in the merger and replaced with an option to purchase 23,040 shares of Quintiles IMS Holdings, Inc. common stock at a price of $29.17 per share."}],"balance_after":0,"derivative":{"exercise_price":11.2,"exercise_date":"2012-07-16","expiration_date":"2021-07-16","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001595262-16-000063","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1595262/000159526216000063/edgar.xml","form_type":"4"}},{"id":4589810,"issuer":{"id":174539,"kind":"organization","name":"IMS Health Holdings, Inc.","symbol":"Q"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2016-10-03T18:54:18.000Z","date":"2016-10-03","kind":"disposition_to_issuer","acquired":false,"shares":148483,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Disposed of pursuant to merger agreement in exchange for 57,017 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001595262-16-000063","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1595262/000159526216000063/edgar.xml","form_type":"4"}},{"id":4589809,"issuer":{"id":174539,"kind":"organization","name":"IMS Health Holdings, Inc.","symbol":"Q"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2016-10-03T18:54:18.000Z","date":"2016-10-03","kind":"grant","acquired":true,"shares":35828,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 2, 2016, the reporting person was granted 26,019 performance-based restricted stock units. The shares are earned based on the company's financial results over a three-year period (January 1, 2016 - December 31, 2018). In connection with the merger and based on the performance criteria achieved, 35,828 shares of issuer common stock were issued to the recipient.  The performance-based restricted stock unit was assumed by Quintiles in the merger and replaced with a time-based restricted stock unit of 13,757 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger.  The shares will vest on December 31, 2018."}],"balance_after":148483,"source":{"system":"sec-edgar","filing":"0001595262-16-000063","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595262/000159526216000063/edgar.xml","form_type":"4"}},{"id":4589808,"issuer":{"id":174539,"kind":"organization","name":"IMS Health Holdings, Inc.","symbol":"Q"},"owners":[{"id":37285,"kind":"person","name":"Bruehlman Ronald E","position":1,"cik":"0001604076","reported_name":"Bruehlman Ronald E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2016-10-03T18:54:18.000Z","date":"2016-10-03","kind":"grant","acquired":true,"shares":20935,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 3, 2016, the issuer and Quintiles Transnational Holdings, Inc. (\"Quintiles\") entered into an Agreement and Plan of Merger pursuant to which on October 3, 2016 the issuer merged with and into Quintiles (the \"merger\"), the separate existence of the issuer ceased and Quintiles will continue as the surviving corporation, operating under the name Quintiles IMS Holdings, Inc."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 10, 2015 the reporting person was granted 17,563 performance-based restricted stock units. The shares are earned based on the company's financial results over a three-year period (January 1, 2015 - December 31, 2017).   In connection with the merger and based on the performance criteria achieved, 20,935 shares of issuer common stock were issued to the recipient.  The performance-based restricted stock unit was assumed by Quintiles in the merger and replaced with a time-based restricted stock unit of 8,039 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger.  The shares will vest on December 31, 2017"}],"balance_after":112655,"source":{"system":"sec-edgar","filing":"0001595262-16-000063","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595262/000159526216000063/edgar.xml","form_type":"4"}}]}